Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34+hematopoietic stem and progenitor cells

被引:12
作者
Cromer, M. Kyle [1 ,2 ,3 ]
Majeti, Kiran R. [4 ]
Rettig, Garrett R. [5 ]
Murugan, Karthik [5 ]
Kurgan, Gavin L. [5 ]
Bode, Nicole M. [5 ]
Hampton, Jessica P. [4 ]
Vakulskas, Christopher A. [5 ]
Behlke, Mark A. [5 ]
Porteus, Matthew H. [4 ]
机构
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med, San Francisco, CA 94143 USA
[4] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[5] Integrated DNA Technol Inc, Coralville, IA 52241 USA
关键词
GENOME; REPAIR; GENERATION; LANDSCAPE; SEQ;
D O I
10.1016/j.ymthe.2023.02.011
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
While a number of methods exist to investigate CRISPR off -target (OT) editing, few have been compared head-to-head in pri-mary cells after clinically relevant editing processes. Therefore, we compared in silico tools (COSMID, CCTop, and Cas-OFFinder) and empirical methods (CHANGE-Seq, CIRCLE-Seq, DISCOVER-Seq, GUIDE-Seq, and SITE-Seq) after ex vivo hematopoietic stem and progenitor cell (HSPC) editing. We per-formed editing using 11 different gRNAs complexed with Cas9 protein (high-fidelity [HiFi] or wild-type versions), then per-formed targeted next-generation sequencing of nominated OT sites identified by in silico and empirical methods. We identified an average of less than one OT site per guide RNA (gRNA) and all OT sites generated using HiFi Cas9 and a 20-nt gRNA were iden-tified by all OT detection methods with the exception of SITE-seq. This resulted in high sensitivity for the majority of OT nomi-nation tools and COSMID, DISCOVER-Seq, and GUIDE-Seq attained the highest positive predictive value (PPV). We found that empirical methods did not identify OT sites that were not also identified by bioinformatic methods. This study supports that refined bioinformatic algorithms could be developed that maintain both high sensitivity and PPV, thereby enabling more efficient identification of potential OT sites without compro-mising a thorough examination for any given gRNA.
引用
收藏
页码:1074 / 1087
页数:14
相关论文
共 54 条
  • [1] Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
    Bae, Sangsu
    Park, Jeongbin
    Kim, Jin-Soo
    [J]. BIOINFORMATICS, 2014, 30 (10) : 1473 - 1475
  • [2] Tools for experimental and computational analyses of off-target editing by programmable nucleases
    Bao, X. Robert
    Pan, Yidan
    Lee, Ciaran M.
    Davis, Timothy H.
    Bao, Gang
    [J]. NATURE PROTOCOLS, 2021, 16 (01) : 10 - 26
  • [3] Quantification of Cas9 binding and cleavage across diverse guide sequences maps landscapes of target engagement
    Boyle, Evan A.
    Becker, Winston R.
    Bai, Hua B.
    Chen, Janice S.
    Doudna, Jennifer A.
    Greenleaf, William J.
    [J]. SCIENCE ADVANCES, 2021, 7 (08)
  • [4] Structural basis for mismatch surveillance by CRISPR-Cas9
    Bravo, Jack P. K.
    Liu, Mu-Sen
    Hibshman, Grace N.
    Dangerfield, Tyler L.
    Jung, Kyungseok
    McCool, Ryan S.
    Johnson, Kenneth A.
    Taylor, David W.
    [J]. NATURE, 2022, 603 (7900) : 343 - 347
  • [5] Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/NMETH.4284, 10.1038/nmeth.4284]
  • [6] Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies
    Chang, Jing
    Peng, Haiyong
    Shaffer, Brian C.
    Baskar, Sivasubramanian
    Wecken, Ina C.
    Cyr, Matthew G.
    Martinez, Gustavo J.
    Soden, Jo
    Freeth, Jim
    Wiestner, Adrian
    Rader, Christoph
    [J]. CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09) : 1008 - 1013
  • [7] Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
    Chaudhari, Hemangi G.
    Penterman, Jon
    Whitton, Holly J.
    Spencer, Sarah J.
    Flanagan, Nicole
    Zhang, Maria C. Lei
    Huang, Elaine
    Khedkar, Aditya S.
    Toomey, J. Mike
    Shearer, Courtney A.
    Needham, Alexander W.
    Ho, Tony W.
    Kulman, John D.
    Cradick, T. J.
    Kernytsky, Andrew
    [J]. CRISPR JOURNAL, 2020, 3 (06): : 440 - 453
  • [8] COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
    Cradick, Thomas J.
    Qiu, Peng
    Lee, Ciaran M.
    Fine, Eli J.
    Bao, Gang
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2014, 3 : e214
  • [9] Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    Cromer, M. Kyle
    Barsan, Valentin V.
    Jaeger, Erich
    Wang, Mengchi
    Hampton, Jessica P.
    Chen, Feng
    Kennedy, Drew
    Xiao, Jenny
    Khrebtukova, Irina
    Granat, Ana
    Truong, Tiffany
    Porteus, Matthew H.
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [10] Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
    Cromer, M. Kyle
    Camarena, Joab
    Martin, Renata M.
    Lesch, Benjamin J.
    Vakulskas, Christopher A.
    Bode, Nicole M.
    Kurgan, Gavin
    Collingwood, Michael A.
    Rettig, Garrett R.
    Behlke, Mark A.
    Lemgart, Viktor T.
    Zhang, Yankai
    Goyal, Ankush
    Zhao, Feifei
    Ponce, Ezequiel
    Srifa, Waracharee
    Bak, Rasmus O.
    Uchida, Naoya
    Majeti, Ravindra
    Sheehan, Vivien A.
    Tisdale, John F.
    Dever, Daniel P.
    Porteus, Matthew H.
    [J]. NATURE MEDICINE, 2021, 27 (04) : 677 - 687